Colitis: Causes, Diagnosis and Treatment

Soren Garcia (Editor)

Series: Digestive Diseases – Research and Clinical Developments
BISAC: MED031000



Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick


Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:



Clostridium difficile and its toxin-producing strains are the most common causative agents of Clostridium difficile infections. It is an inflammatory bowel disease predominantly caused by prior antibiotic treatment. The use of broad spectrum antibiotics suppresses bacterial intestinal microflora and causes overgrowth of the Clostridium difficile, and often occurs in immunocompromised, older and polymorbid patients.

Following this, the authors discuss inflammatory bowel disease (including ulcerative colitis), a complex, multifactorial disease of unknown etiology. Intestinal sulfate-reducing bacteria, especially Desuflovibrio, are often found in the intestines and feces of people and animals with inflammatory bowel disease.

Of late, the incidence of autoimmune colitis both in adults and children has been progressively increasing globally. The efficacy of conventional therapeutic measures is questionably limited due to short-term immunosuppressive effect along with possible serious side effects. As such, the authors present evidence from epidemiological studies that has demonstrated an inverse relationship between the occurrence of parasitic diseases and various autoimmune pathologies.
(Imprint: Nova Medicine and Health)


Chapter 1. Infections of Clostridium Difficile
(L. Palcová, A. Lesňáková, B. Matúšková, Institute of Clinical Microbiology, Central Military, Ružomberok, Slovakia, and others)

Chapter 2. Sulfate Source and Its Role in the Development of Colitis
(Ivan Kushkevych, Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic)

Chapter 3. Helminth Therapy: A Promising Biotherapeutic Approach for Autoimmune Colitis
(Kalyan Goswami, MD; Vishal Khatri, PhD, Nitin Amdare, PhD, Namdev Togre, PhD, Priyanka Bhoj, PhD, Department of Biochemistry, All India Institute of Medical Sciences, Kalyani, WB, India, and others)


You have not viewed any product yet.